98 related articles for article (PubMed ID: 9461034)
1. No association between immunohistochemical expression of p53, c-erbB-2, Ki-67, estrogen and progesterone receptors in female papillary thyroid cancer and ionizing radiation.
Karlsson MG; Hardell L; Hallquist A
Cancer Lett; 1997 Dec; 120(2):173-7. PubMed ID: 9461034
[TBL] [Abstract][Full Text] [Related]
2. Selected immunohistochemical prognostic factors in endometrial cancer.
Markova I; Duskova M; Lubusky M; Kudela M; Zapletalová J; Procházka M; Pilka R
Int J Gynecol Cancer; 2010 May; 20(4):576-82. PubMed ID: 20686376
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
Sun X; Mittal K
Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
[TBL] [Abstract][Full Text] [Related]
4. Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program.
González-Sistal A; Sánchez AB; Del Rio MC; Arias JI; Herranz M; Ruibal A
Anticancer Res; 2014 Jan; 34(1):269-73. PubMed ID: 24403473
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].
Fang Q; Wang XF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):380-2. PubMed ID: 21354936
[TBL] [Abstract][Full Text] [Related]
6. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
7. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor, progesterone receptor, HER2/neu, P53 and Ki-67 status of male breast carcinomas in Pakistan.
Jamal S; Mushtaq H; Mubarik A; Malik TM
Asian Pac J Cancer Prev; 2009; 10(6):1067-70. PubMed ID: 20192585
[TBL] [Abstract][Full Text] [Related]
9. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
10. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
[TBL] [Abstract][Full Text] [Related]
12. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].
Negoiţă M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):834-8. PubMed ID: 22046795
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in young women: prognostic factors and clinicopathological features.
Aryandono T; Harijadi ; Soeripto
Asian Pac J Cancer Prev; 2006; 7(3):451-4. PubMed ID: 17059343
[TBL] [Abstract][Full Text] [Related]
15. Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer.
Qin Q; Gao F; Jiang W; Tan Q; Mo Q; Wei C
Chin Med J (Engl); 2014; 127(18):3272-7. PubMed ID: 25266526
[TBL] [Abstract][Full Text] [Related]
16. Definition of p53 overexpression and its association with the clinicopathological features in luminal/HER2-negative breast cancer.
Kikuchi S; Nishimura R; Osako T; Okumura Y; Nishiyama Y; Toyozumi Y; Arima N
Anticancer Res; 2013 Sep; 33(9):3891-7. PubMed ID: 24023325
[TBL] [Abstract][Full Text] [Related]
17. Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer.
Bandala C; De la Garza-Montano P; Cortes-Algara A; Cruz-Lopez J; Dominguez-Rubio R; Gonzalez-Lopez JN; Cardenas-Rodriguez N; Alfaro-Rodriguez A; Salcedo M; Floriano-Sanchez E; Lara-Padilla E
Asian Pac J Cancer Prev; 2015; 16(18):8397-403. PubMed ID: 26745092
[TBL] [Abstract][Full Text] [Related]
18. Histological and immunohistochemical features of medullary breast cancer.
Romaniuk A; Lyndin M; Sikora V; Lyndina Y; Panasovska K
Folia Med Cracov; 2015; 55(2):41-8. PubMed ID: 26839242
[TBL] [Abstract][Full Text] [Related]
19. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
Akslen LA; Varhaug JE
Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
[TBL] [Abstract][Full Text] [Related]
20. [Detection and assessment of Ki-67 in breast cancer].
Shui RH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):420-3. PubMed ID: 24060083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
